STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia. Linder A, Nixdorf D, Kuhl N, Piseddu I, et al. Blood 2025 Feb 26:blood.2024026934. doi: 10.1182/blood.2024026934.

Read + Share

Amedeo Smart

Independent Medical Education

Linder A, Nixdorf D, Kuhl N, Piseddu I, et al. STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia. Blood 2025 Feb 26:blood.2024026934. doi: 10.1182/blood.2024026934.
PMID: 40009483